From Financialpost · · 1m
Realbotix Gets $500k Bridge Loan from Onconetix
Realbotix secures $500k additional draw under bridge loan from Onconetix to fund merger.
In brief
Realbotix secures $500k additional draw under bridge loan from Onconetix to fund merger. Realbotix Corp. received an additional $500,000 bridge loan from Onconetix to advance their merger transaction. Originally reported by Financialpost.
Realbotix Announces Additional Draw
Realbotix Corp. (TSX-V: XBOT) has agreed to an additional advance of US$500,000 under the bridge loan with Onconetix.
Bridge Loan Details
The loan increases total advanced funds from US$2,500,000 to US$3,000,000 out of a US$5,000,000 facility.
Loan Terms
The unsecured promissory note is non-interest-bearing and automatically cancels upon merger completion.
CEO Statement
Andrew Kiguel, CEO of Realbotix, stated the loan provides greater commitment to complete the merger transaction.
Merger Background
Realbotix and Onconetix previously announced a merger on February 12, 2026, with the bridge loan tied to the transaction.
Loan Termination Clause
If the merger is terminated, interest accrues at 12% per annum on the outstanding principal from termination date.
At a glance
Realbotix Corp. received an additional $500,000 bridge loan from Onconetix to advance their merger transaction.
